Microbio Co., Ltd.(TW:4128)
NT$13.45-0.10 (-0.74%)
TW:4128
Microbio Co., Ltd. financials statements
NT$13.45
At close:-0.10 (-0.74%)
Microbio Co., Ltd. (4128) Financial Statements
Microbio Co., Ltd. Financial Overview
Microbio Co., Ltd.'s market cap is currently NT$7.85B. The company's EPS TTM is NT$0.90; its P/E ratio is 24.61; and it has a dividend yield of 0.07%. Microbio Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.89B | NT$ 1.72B | NT$ 1.59B | NT$ 1.72B | NT$ 1.78B |
| Gross Profit | NT$ 753.46M | NT$ 676.08M | NT$ 603.88M | NT$ 691.29M | NT$ 739.37M |
| Operating Income | NT$ -406.62M | NT$ -451.14M | NT$ -506.47M | NT$ -278.85M | NT$ -225.65M |
| EBITDA | NT$ -665.16M | NT$ -1.00B | NT$ -1.13B | NT$ 400.40M | NT$ 44.55M |
| Net Income | NT$ -757.75M | NT$ -1.10B | NT$ -1.18B | NT$ 211.20M | NT$ -233.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 2.65B | NT$ 2.57B | NT$ 3.66B | NT$ 4.10B | NT$ 4.06B |
| Total Assets | NT$ 12.33B | NT$ 13.93B | NT$ 14.74B | NT$ 15.09B | NT$ 15.02B |
| Total Debt | NT$ 670.59M | NT$ 617.62M | NT$ 621.34M | NT$ 490.28M | NT$ 519.30M |
| Net Debt | NT$ -56.19M | NT$ -55.66M | NT$ 4.30M | NT$ -641.79M | NT$ -206.40M |
| Total Liabilities | NT$ 2.13B | NT$ 2.06B | NT$ 1.23B | NT$ 1.08B | NT$ 1.17B |
| Stockholders' Equity | NT$ 8.91B | NT$ 10.31B | NT$ 11.81B | NT$ 12.09B | NT$ 11.89B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 21.97M | NT$ 489.67M | NT$ -166.80M | NT$ 98.45M | NT$ -49.98M |
| Operating Cash Flow | NT$ 82.76M | NT$ 529.90M | NT$ -118.75M | NT$ 141.57M | NT$ 53.98M |
| Investing Cash Flow | NT$ 106.34M | NT$ -302.05M | NT$ -211.00M | NT$ 334.56M | NT$ 19.81M |
| Financing Cash Flow | NT$ -157.05M | NT$ -166.86M | NT$ -163.08M | NT$ -67.12M | NT$ -42.19M |
Currency in TWD
